N02.421.668.438
Sponsors
Universidade Federal de Pernambuco, Universidade Federal de São Paulo - UNIFESP/EPM, GlaxoSmithKline, GlaxoSmithKline Brasil, Hospital Universitário Pedro Ernesto
Conditions
Chronic obstructive pulmonary diseaseCystic FibrosisErectile dysfunction due to organic causePersistent asthmaPityriasis versicolor.Plasmodium vivax, malariaPulmonary HypertensionPulmonary hypertension
Phase 2
A clinical study to evaluate the efficacy and safety of Ambrisentan on Pulmonary Arterial Hypertension in patients aged 8 years up to 18 years
Active, not recruitingRBR-8vvwj8
Start: 2011-01-04Updated: 2025-10-27
Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529
RecruitingRBR-7jcvv4
Start: 2011-06-21Updated: 2025-10-27
Benzbromarone medication treatment to improve Respiratory Health and Quality of Life for patients with Cystic Fibrosis
Active, not recruitingRBR-5wvg53s
Start: 2021-05-01Updated: 2025-10-27
Phase 3
Efficacy and tolerability of Meclin® (meclizine hydrochloride) in Acute vertigo (a type of dizziness) and other types of dizzy spells identified by Otorhinolaryngologist
Active, not recruitingRBR-3pyzt5
Start: 2015-03-23Updated: 2025-10-27
A study of eltrombopag in combination with azacitidine for subjects with low platelet counts due to intermediate 1, intermediate 2 or high risk Myelodysplastic Syndromes.
RecruitingRBR-4m42nq
Start: 2014-05-23Updated: 2025-10-27
Efficacy and safety study of Fluticasone Furoate/Vilanterol on the dose of 100/25 microgram (mcg) inhalation powder, Fluticasone Propionate/Salmeterol on the dose of 250/50 mcg inhalation powder and Fluticasone Propionate on the dose of 250 mcg inhalation powder in adults and adolescents with persistent asthma
RecruitingRBR-4f9tcc
Start: 2015-03-09Updated: 2025-10-27
CTT116855 Twelve month study to compare three investigational medications in patients with chronic obstructive pulmonary disease who have a history of COPD exacerbation
Active, not recruitingRBR-4sxpff
Start: 2014-06-30Updated: 2025-10-27
TAF116564 Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria
Active, not recruitingRBR-48zmp6
Start: 2016-01-18Updated: 2025-10-27
Botulinum Toxin Injections for Men with Erectile Dysfunction
RecruitingRBR-5kkspwk
Start: 2024-03-01Updated: 2025-10-27